Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCP vs DAP in Pemphigus Vulgaris
NCT06846255Phase 4Completed
- Sponsor
- Jinnah Postgraduate Medical Centre
- Start
- Jun 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclophosphamide, azathioprine in pemphigus vulgaris (PV), sponsored by Jinnah Postgraduate Medical Centre. Started Jun 2021; status: completed.
02
Drugs
cyclophosphamideazathioprine
03
Conditions
pemphigus vulgaris (PV)
Beyond the preview
Go deeper on NCT06846255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06846255.